Dow Up 0.85% Nasdaq Up 1.12%

Hyperion Therapeutics, Inc. (HPTX)

-NasdaqGS
24.24 Down 0.19(0.78%) 2:45PM EDT - Nasdaq Real Time Price
Prev Close:24.43
Open:24.98
Bid:24.22 x 100
Ask:24.27 x 100
1y Target Est:38.17
Beta:0.89
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:24.19 - 25.44
52wk Range:18.97 - 32.98
Volume:60,652
Avg Vol (3m):146,829
Market Cap:499.27M
P/E (ttm):26.93
EPS (ttm):0.90
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
HPTXDown 0.78%499.27M
ALXNDown 1.33%37.75B
CPIXUp 1.03%86.13M
SLXPUp 0.05%9.21B

Key Statistics

Forward P/E (1 yr):346.71
P/S (ttm):5.55
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.54
Quarterly EPS Est (Sep-14) :-0.13
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Hyperion Therapeutics, Inc., a commercial biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat disorders in the areas of orphan diseases and hepatology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback